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The process of metabolic engineering consists of multiple cycles of design, build, test and learn, which is
typically laborious and time-consuming. To increase the efﬁciency and the rate of success of strain en-
gineering, novel instrumentation must be applied. Microﬂuidics, the control of liquid ﬂow in micro-
structures, has enabled ﬂexible, accurate, automatic, and high-throughput manipulation of cells in liquid
at picoliter to nanoliter scale. These attributes hold great promise in advancing metabolic engineering in
terms of the phases of design, build, test and learn. To promote the application of microﬂuidic-based
technologies in strain improvement, this review addressed the potentials of microﬂuidics and the
related approaches in DNA assembly, transformation, strain screening, genotyping and phenotyping, and
highlighted their adaptations for single-cell analysis. As a result, this facilitates in-depth understanding
of the metabolic network, which in turn promote efﬁcient optimization in the following cycles of strain
engineering. Taken together, microﬂuidic-based technologies enable on-chip workﬂow, and could greatly
accelerate the turnaround of metabolic engineering.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Contents
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The development of cell factories undergoes multiple cycles ofng by Elsevier B.V. on behalf of KeAdesign, build, test and learn. Each cycle is likely to improve the
yield, efﬁciency and the stability of the strain, and ultimately, the
desired strain capable of industrial production is acquired. How-
ever, the robust and complex metabolic network is usually insus-
ceptible to manipulations, thus a single cycle of strain development
can take months and typically nearly a decade with millions of
dollars spent to meet with industrial requirements [1]. This greatlyi Communications Co. This is an open access article under the CC BY-NC-ND license
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To speed up the process of strain construction and exploit the
potential of cell metabolism, a series of techniques have been
developed and applied to different levels of metabolic engineering,
such as the tuning of the promoter strength at the gene level [2],
the elimination of the competing pathways [3], and the identiﬁ-
cation of additional beneﬁcial enzymes by omics analysis of the
whole cell system [4]. However, conventional methods are often
limited by the throughput, precision, cost, convenience and the
compatibility with other assays. These defects were overcame by
microﬂuidics, which is the technology of manipulating and con-
trolling the ﬂow of liquids inside micrometer-sized channels, re-
agent wells and reaction chambers. It usually appears in two forms:
stream of ﬂuids and droplet. The latter is comprised of two
immiscible ﬂuids such as buffer and oil, droplets are formed via
shearing one into the other [5]. The microﬂuidics are characterized
by laminar ﬂow, surface effects, short diffusion length and small
volume [6,7]. Laminar ﬂow induces a predictable stream behavior
and minimal mixing, and surface effects facilitate capillary liquid
drawing, interfacial transport and reactions. Meanwhile, the min-
ute length and volume scale enable rapid changes in temperature
and chemical composition. These attributes ensure accurate control
over the ﬂow at picoliter to nanoliter scale under automated mode,
hence higher throughput and precision (Table 1). Along with
reduced cost and labor, as well as ﬂexible integration with sensors,
actuators, and controllers, the microﬂuidic methods exhibit
promising applications in the systems level of strain optimization,
offering unprecedented opportunities for improving yield and
strain stability [8].
To encourage the implement of microﬂuidics in metabolic en-
gineering, we reviewed the revolutions brought by this approaches
in the key processes of strain development including design, build,
test and learn. Meanwhile, we emphasized the realization of single-
cell analysis for metabolic engineering thanks to the combined
utilization of microﬂuidics and the downstream approaches. We
believe that themicroﬂuidic technologies could accelerate the cycle
of metabolic engineering toward a rapid turnaround by following
its own “Moore's law”, just like the electronic industry.
2. Microﬂuidics in the realization and decision-making of
metabolic design
The process of metabolic engineering begins with the step of
design. It includes the selection of host and the creation of the
synthetic pathways capable of overproducing the chemicals of in-
terest. The blueprint of metabolic pathways is usually drafted in
silico, with the aid of computer algorithms to design the most
feasible and efﬁcient routes using the data from a set of databases.
Although the design phase does not involve with in vivo or
in vitro operations, it is linked withmicroﬂuidic-based technologies
(Fig. 1). Their application in metabolic design was attributed to the
high-throughput and high-resolution of microﬂuidics. Due to their
higher throughput than conventional approaches, combining
microﬂuidics with supporting algorithms will reduce labor in the
process of metabolic design [9]. For instance, microﬂuidic trappingTable 1
The characteristics of microﬂuidics compared with conventional approaches.
Approaches Sample volume Throughput Integration M
Conventional Microliter Low (usually <107) Complex Di
Microﬂuidics Pico to nanoliter High (can reach 109) Flexible Ea
Pros or cons ✓ ✓ ✓ ✓
a Molecule adsorption is the adsorption of hydrophobic molecules to the surface due
concentrations of reagents.devices have recently been used to characterize the biophysical
properties of transcription factor binding sites at a throughput up
to 4000 [10]. With the aid of computational tools capable of
detecting motifs in large dataset [11], the proper binding strength
could be easily selected and incorporated into the genetic design.
The advantage of high-resolution enables precise design of the
metabolic pathway. For instance, metabolic information collected
at the scale of single cells by using droplet microﬂuidics considers
the variation of individuals rather than the metabolic state of the
whole cell population. This increases the accuracy of the estimated
coefﬁcients in the ﬂux balance analysis and may also uncover new
pathways, enabling more reliable calculation of the theoretical
yield and the allocation of metabolites [12], thus guiding the design
of the optimal metabolic pathway that achieves the highest yield.
Moreover, the resources, rules and tools for metabolic designs are
increasing rapidly, which broadened the diversity of chemicals that
could be produced by metabolic engineering [13]. This also calls for
coupled improvement of the analytical technologies to fulﬁll the
design space in order to exploit the potentials of metabolic engi-
neering in modern industry. Compared with conventional ap-
proaches, microﬂuidics is one of themost cutting edge technologies
featuring high sensitivity, accuracy, high-throughput and other
advantages, which can expedite the realization of metabolic design.
At last, the initial design is mostly always ﬂawed. The errors or
bottlenecks must be identiﬁed and revised in the subsequent
redesigning. Microﬂuidics enables the integration of the omics
platform [14]. Data acquired from the systematic studies of
metabolomics, proteomics, genomes and transcriptomes provide
quantitative information of the interactions within the complex cell
network, offering new strategies for strain improvement. For
example, the integration of transcriptomic and proteomic analysis
has been used to uncover the competing pathway of phosphoenol
pyruvate carboxykinase in the production of threonine, deletion of
the related targets increased the productivity of threonine by more
than 40% [15].
3. Microﬂuidics facilitates strain building
The build step introduces exogenous pathways into the host and
directs the metabolic ﬂuxes towards the production of desired
chemicals in accordance to the prior design. This phase involves the
synthesis, assembly and transformation of DNA into the chassis
host, for which microﬂuidic platforms have recently been intro-
duced to expedite this process.
3.1. DNA assembly
To obtain novel pathways, fragments of DNA encoding different
functions must be assembled into the vector. The traditional
manual procedures were laborious and time-consuming. Although
the automatic robotic techniques have reached the level of high-
throughput, their application was limited by the high cost in
equipments and consumable assays [16]. Fortunately, microﬂuidics
overcome these defects by reducing processing time, reagents
consumption (100-fold), DNA loss, and by offering facile controlanipulation Cost Labor Solution mixing Molecule adsorptiona
fﬁcult High High Fast Difﬁcult
sy Low Low Slow Easy
✓ ✓ 7 7
to the large surface-to-volume ratios of microﬂuidic devices, which may affect the
Fig. 1. The application of microﬂuidic-based approaches in the cycle of metabolic engineering. The inner circle indicates the steps where microﬂuidic approaches could be applied;
the middle circle shows the speciﬁc contents; the outer circle lists the combined strategies or methods. FACS: ﬂuoresence-activated cell sorting, FADS: ﬂuoresence-activated droplet
sorting, MS: mass spectrometry, MDA: multiple displacement ampliﬁcation, SMRT: single molecule, real-time sequencing.
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with different functional components have been designed to inte-
grate DNA digestion and ligation into a single run [17]. Digital
microﬂuidic devices imbedded with electrodes have achieved even
higher precision and reproducibility [18]. These platforms have
been successfully adopted to generate large libraries of plasmids
following protocols such as Gibson assembly, Golden gate assem-
bly, and yeast assembly [19].
3.2. Transformation
After construction, the plasmids must be transferred into the
cell to perform functions. The efﬁciency of transformation ensures
the size of the genetic libraries, which correlates positively with the
probability of the occurence of the desired mutant. By incorpo-
rating either heat-shock or electroporation procedures, trans-
formation using microﬂuidic platforms have been proved to
achieve at least the comparable efﬁciencies for E. coli and
S. cerevisiae as the tube-based approaches [19,20]. Moreover, the
microﬂuidic-based approaches are much cheaper and convenient.
Further optimization such as the utilization of magnetic beads can
improve the transformation efﬁciency up to 2-fold [21]. These ad-
vantages allowed routine construction of large genetic libraries.
4. Increased efﬁciency and accuracy in the test step
The test step validates the efﬁcacy of the design and buildphases in achieving the desired properties. It includes the charac-
terization, screening and analysis of the engineered strain in terms
of cell phenotype and genotype.
4.1. High-throughput screening
The build process generates large genetic libraries with high
diversity, which have to be screened based on the phenotypic or
genotypic characteristics of the cells. Since the occurence of the
target properties can be rather infrequent, usually 104, the size of
the mutant libraries is typically 105, with maxima up to 1012 [22].
Accordingly, high-throughput analysis is essential for detecting the
desired mutant from such a large pool. Traditional screening was
performed using microtiter well plates, and the contents of the
metabolites of interest are measured as indicators for screening.
This method is low-throughput, time consuming, laborious and
costly, thus is less likely to acquire the optimal strains.
In contrast, microﬂuidic platforms can achieve high efﬁciency by
using the ﬂuorescent properties of the cells as reporters. For small
molecules that emit no spectral signature, ﬂuoresence could be
realized by linking the ﬂuorescent gene to the gene of interest.
Another strategy is to use biosensors. These are substrates capable
of entering cells or attached to the cell membranes, and can be
converted to ﬂuorescent reporters by enzymatic reactions to reﬂect
the contents of the desired metabolites [5]. These enabled the
application of ﬂuoresence-activated cell sorting (FACS) for the
screening of genetic libraries [22]. The FACS is suitable for stream-
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which increases the throughput to 108 variants per day [23].
However, this method only allows the detection of intracellular
metabolites, or metabolites attached to the cell membrane without
diffusing into the ﬂuid. For secretory metabolites, the latest
ﬂuoresence-activated droplet sorting (FADS) serves the purpose
[24,25]. The droplet microﬂuidics isolates single cell into individual
compartment and preserves the unique phenotypic characteristics
of the cell. By employing electrical, acoustic, magnetic, optical,
hydrodynamic and mechanical approaches [26], the FADS droplet
microﬂuidics has enabled a high screening rate of 106 cells per hour.
Further modiﬁcation such as device parallel can increase the
throughput by another three orders of magnitude [27]. Due to this
merit, microﬂuidic platforms have been successfully applied to
strain screening. For instance, yeast strains capable of over-
consuming xylose were acquired using microﬂuidics from a library
of 105 clones [27], and at a rate of 300 droplets per second, strains
with high a-amylase yield were isolated in a total of 106 cells within
3 h [25].
Another major advantage of microﬂuidics is the facilitation of
ﬁne-scale spatial and temporal control of the cells. By using
microwells, microchambers, droplets, hydrogels and other contact
or contactless trappings, cells could be easily manipulated in zero to
three dimensional spaces [5,26]. This enables batch cultivation of
single or multiple cells in the upstream or downstream of the
microﬂuidics workﬂow. For instance, the droplet trapping has been
used for short-term culturing of the single cells, allowing secretory
metabolites to accumulate and ready for FADS screening [27,28].
Moreover, the high controllability of microﬂuidics enables facile
changes in the microenvironment around the cell. This could be
adapted to optimize strain stability, such as the ability to withstand
concentrated end product, as well as the ability to sustain high
productivity over the course of cell growing phases.
4.2. Single cell analysis
Strain screening is often coupled with phenotype and genotype
of the cells to validate the manipulations of the pathway, which
enable global analysis of the cellular metabolites. Conventionally,
the measurement is based on the average information of a whole
cell population. However, cells are highly heterogeneous systems.
Due to stochastic gene expression, cell cycle, aging, epigenetic
regulation and microenvironments, they can present unique
properties that differ signiﬁcantly from the mean levels in terms of
gene translation and expression, even for isogenic populations in
identical environments [26,29]. Thus, single cell analysis at the
systems level can provide new possibilities to uncover rare mech-
anisms of the metabolic regulations, which may lead to great
improvement in strain performances.
The feasibility of single cell analysis in metabolic engineering
depends on two factors: cell sorting and downstream assays. The
throughput issue concerning cell sorting is better fulﬁlled by
automated droplet microﬂuidics using FADS method, in compari-
son to the conventional approaches such as optical tweezers, serial
and microwell dilutions [30]. On the other hand, the sensitivity,
ﬁdelity and throughput become the major challenges for down-
stream measurements. Fortunately, these issues have been
addressed by the recent development in analytical technologies.
The analysis of proteomics andmetabolomics for single cells has
been realized thanks to the increased sensitivity and resolution of
the latest mass spectrometry (MS). The MS has been the ideal de-
vice to identify and quantify the complex mixtures containing
thousands of analytes in biological samples [31]. The detection limit
of the latest MS devices has reached attomole level [32], which is
suitable for the analysis of proteins and metabolites from singlecells. However, the low throughput of MS-based approaches still
conﬁnes their utilization in large-scale analysis. Recent solutions
such as mass spectrometry imaging has increased the number of
measured samples per run [33]. Nevertheless, future development
of MS-based approaches should incorporate both the sensitivity
and throughput. One promising solution is the integration of
microﬂuidics, by reducing sample volume, it improves MS sensi-
tivity and resolution, and facilitate parallel detection for large-scale
analysis. This will allow unrestricted access to diverse types of trace
molecules, which could be more relevant to the desired metabolic
characteristics. The protein expression, enzymatic activity and
metabolite levels can also be extracted from the identical cells,
enabling the establishment of direct metabolite-protein in-
teractions, and subsequent evaluation of their feedbacks on gene
expression and signaling [34].
For the measurements of cell genome and transcriptome, one
strategy to increase throughput is double barcoding, which tags
both the cell and the genetic molecules. The method is based on
droplet microﬂuidics and is hence referred to drop sequencing
(drop-seq) [35]. Take transcriptome for instance, the cell barcode
usually consists of 12 bases that has the potential to distinguish 412
(16,777,216) individual cells, for each cell barcode, a unique mo-
lecular identiﬁer of 8 bases is then attached, enabling it to mark 48
(65,536) different mRNAs in a single cell. The barcode and cell are
co-encapsulated in a droplet, after the binding of mRNAs and
reverse transcription. The transcriptome from a single cell is tagged
uniquely, allowing parallel sequencing in a single run [35,36]. The
current throughput for drop-seq is 104 cells per day, although still
an order of magnitude lower than the typical size of a mutant li-
braries, it already shortened the processing time by > 100-fold
comparing with the existing methods [35], and has realized
routine genotyping of single cells. This can rapidly reveal signiﬁcant
differences in the gene transcription level among individual cells,
aiding parallel validation of the efforts in modifying targeted genes.
The comparative analysis of genome and transcriptome among
different cells helps to identify the key genetic factors that endow
the desired phenotypes, facilitating directed manipulation of other
strains in the process of inverse metabolic engineering [37].
Moreover, the single-cell omic analysis captures a “snap-shot” of
the cell status, a series of “snap-shots” will create a dynamic record
of the cellular metabolism, offering timing and causal analysis of
the metabolic regulation mechanisms.
The ﬁdelity of the ampliﬁed genome is crucial for single-cell
analysis since the initial copy number is only one. The traditional
PCR-basedmethod is highly biased due to its low coverage and high
rate of ampliﬁcation error [30], thus is not suitable for single-cell
analysis. A better strategy is to use isothermal approaches such as
multiple displacement ampliﬁcation (MDA) [38]. This method
generates greater genome coveragewith lower error rate compared
to PCR-based methods. However, the lack of uniformity for MDA
method may introduce bias in the ﬁnal data. To compensate these
defects, hybrid methods such as multiple annealing and looping-
based ampliﬁcation cycles (MALBAC) has been proposed to strike
a balance between the PCR-based and the MDA methods. The
MALBAC achieves medium coverage and error rate with high uni-
formity, and is considered an alternative for MDA method [30]. In
terms of single cells, the ampliﬁcation bias for both MDA and
MALBACmethods are rather similar, but with different preferences.
The former one has much lower error rate whereas the latter is
better at detecting variations in copy numbers. In all, the amplicon-
based methods are intrinsically ﬂawed for single cell genotypic
analysis.
The third-generation sequencing technologies realized an
amplicon-free, single molecule-based direct DNA or RNA
sequencing [39], which eliminates the bias resulted from the
Fig. 2. The schematic of the integration of droplet microﬂuidics, cell barcoding and sequencing techniques for single cell genetic analysis. FADS: ﬂuoresence-activated droplet
sorting; UMI: unique molecular identiﬁer.
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single molecule, real-time (SMRT) sequencing. It adopts a
sequencing-by-synthesis approach in which a circular template,
usually a DNA molecule, is targeted by a single DNA polymerase.
The type of nucleotide is identiﬁed when it is incorporated by the
DNA polymerase, according to changes in the ﬂuorescence of the
nucleotide. Another advantage of SMRT is the long reads length up
to 20 kb [40], which facilitates accurate genome assembly. The error
in SMRT sequencing derives primarily from insertions, followed by
deletions, and a small chance of mismatch, which are all random
and will not increase with the increase of read length [41]. It has
been claimed that the SMRT was of low accuracy [42], in fact, this
only applies to a single read (~90% accuracy) [43]. By increasing
sequencing depth and implementing a circular consensus
sequence, the SMRT can achieve a ﬁnal accuracy up to 99.999%
[44,45].
An alternative single molecule sequencing method is the
nanopore sequencing, in which the nucleotide is identiﬁed by
detecting the changes in current when strands of DNA pass through
the nanopore [46]. Besides advantages of ampliﬁcation-free and
long read length, this method also offered a high portability and
easy preparation of the templates [47]. However, compared with
SMRT, the accuracy of nanopore sequencing requires further
improvement [48]. Nevertheless, supported by microﬂuidic-based
cell sorting and efﬁcient barcoding, the single molecule
sequencing techniques hold great promise for single cell genotypic
analysis (Fig. 2).5. Microﬂuidics enables deep learning
Learn is usually neglected in current metabolic engineering
practice, yet perhaps the most crucial step to ensure successful
engineering. The learn phase investigates the test results and
guides subsequent strain design and build. This step typically lacks
robust, targeted and systematic data to generate global proﬁles of
the metabolic networks [1,14]. Fortunately, the development in
microﬂuidic-based and related approaches encourages reexami-
nation of this process.
The microﬂuidics revolutionized the learning of metabolic en-
gineering by providing big data, increasing speciﬁcity, and deep-
ening the systematic analysis to the level of single cells. The high-
throughput construction of genetic libraries increases the proba-
bility of positive mutations, and the subsequent screening tech-
niques facilitate the reﬁnement of targeted information. The singlecell analysis may be the most signiﬁcant advancement for meta-
bolic engineering. It enables a closer look at the diverse regulatory
mechanism of the cell, and reveals the rare but key pathways which
are easily masked by the mean data. Together with the facile
manipulation of cells in microﬂuidic platforms, it is able to study
the genetic and phenotypic responses of cells to different micro-
environments and cell cycles. For instance, microﬂuidic coupled
with optical tweezers was able to manipulate the microenviron-
ment around single cells in less than 2 s, and has been used to study
the intracellular responses of single yeast cells to changes in
glucose availability [49]. Using microﬂuidic bioreactor, single cells
such as yeast can also be cultivated for generations in constant
environment, allowing unbiased investigation of the effects of cell
cycle on cell biochemical heterogeneity [50,51]. Findings from
these studies can offer new insights for pathway modeling, design
and strain construction, and ultimately increase the rate of success.6. Outlook and conclusions
The microﬂuidic-based technologies are characterized by high-
throughput, small volume, easy control, low cost, and ﬂexible
integration with other assays. These qualify microﬂuidics as the
ideal choice for metabolic engineering, which covers the steps of
DNA assembly, transformation, strain screening, genotyping, phe-
notyping, and in-depth systems analysis. Moreover, the combined
application of ﬂuorescent-based cell sorting, barcoding and single
molecule sequencing opens the gate of single cell analysis for
metabolic engineering, which hold great promise in the near
future. The era of microﬂuidic-based metabolic engineering has
just begun, and the microﬂuidic platforms should move toward
modularity to speed up its application. This will allow standard
components for various steps such as strain build, screening and
sequencing to be assembled into an engineering line for different
purposes. The seamless and ﬂexible integration of functional units
can avoid extra procedures for sample handling and transferring,
and enable automation. Taken together, the microﬂuidic-based
technologies hold the potential to miniaturize the process of
metabolic engineering to on-chip scale, and greatly reduce the
turnaround of the engineering cycle.Acknowledgements
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